• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Bristol Myers Squibb`s Biologic Orencia (abatacept) Receives Approval in the U.S.

    FDA

    Coya announces an Agreement with Dr. Reddy’s to License biosimilar Abatacept

    BUSINESSWIRE

    NIH-led Covid-19 trial shows immune modulator drugs boost survival

    CLINICALTRIALSARENA

    BMS’ Orencia boosts survival in Phase III Covid-19 trial

    CLINICALTRIALSARENA

    Immune modulator drugs improves survival for people hospitalised with COVID-19

    EXPRESS PHARMA

    Bristol Myers` Biologic Orencia (Abtacept) Receives Approval in the U.S.

    FDA

    BMS`s Orencia wins FDA nod for prevention of GVHD

    FIERCEPHARMA

    BMS` Orencia snagged priority review in transplant rejection

    FIERCEPHARMA

    Bristol Myers`s Orencia (Abatacept ) Receives Supplemental Approval in US

    FDA

    Abbvie`s Rinvoq matches BMS` Orencia in head-to-head RA trial

    FIERCE PHARMA

    AbbVie Presents Data Showing RINVOQ™ (upadacitinib) Meets Primary

    PRESS RELEASE

    BMY`s Precision-Focused Immunology Leadership with New Data on ORENCIA®

    PRESS RELEASE

    Momenta calls time on biosimilar R&D, cuts half its staff

    FIERCE BIOTECH

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.